Cargando…
Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders
Benzodiazepines have proven to be highly effective for treating insomnia and anxiety. Although considered safe when taken for a short period of time, a major risk–benefit dilemma arises in the context of long-term use, relating to addiction, withdrawal symptoms, and potential side effects. For these...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508349/ https://www.ncbi.nlm.nih.gov/pubmed/34639523 http://dx.doi.org/10.3390/ijerph181910222 |
_version_ | 1784582075771256832 |
---|---|
author | Chapoutot, Mélinée Peter-Derex, Laure Bastuji, Hélène Leslie, Wendy Schoendorff, Benjamin Heinzer, Raphael Siclari, Francesca Nicolas, Alain Lemoine, Patrick Higgins, Susan Bourgeois, Alexia Vallet, Guillaume T. Anders, Royce Ounnoughene, Marc Spencer, Jessica Meloni, Francesca Putois, Benjamin |
author_facet | Chapoutot, Mélinée Peter-Derex, Laure Bastuji, Hélène Leslie, Wendy Schoendorff, Benjamin Heinzer, Raphael Siclari, Francesca Nicolas, Alain Lemoine, Patrick Higgins, Susan Bourgeois, Alexia Vallet, Guillaume T. Anders, Royce Ounnoughene, Marc Spencer, Jessica Meloni, Francesca Putois, Benjamin |
author_sort | Chapoutot, Mélinée |
collection | PubMed |
description | Benzodiazepines have proven to be highly effective for treating insomnia and anxiety. Although considered safe when taken for a short period of time, a major risk–benefit dilemma arises in the context of long-term use, relating to addiction, withdrawal symptoms, and potential side effects. For these reasons, benzodiazepines are not recommended for treating chronic sleep disorders, anxiety disorders, nor for people over the age of 65, and withdrawal among long-term users is a public health issue. Indeed, only 5% of patients manage to discontinue using these drugs on their own. Even with the help of a general practitioner, this rate does not exceed 25 to 30% of patients, of which approximately 7% manage to remain drug-free in the long term. Cognitive Behavioral Therapies (CBT) offer a crucial solution to this problem, having been shown to increase abstinence success to 70–80%. This article examines traditional and novel CBT techniques in this regard, such as Acceptance and Commitment Therapy, which address both the underlying condition (insomnia/anxiety) and the substance-related disorder. The theoretical framework and evidence supporting the use of these approaches are reviewed. Finally, current research gaps are discussed, and key research perspectives are proposed. |
format | Online Article Text |
id | pubmed-8508349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85083492021-10-13 Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders Chapoutot, Mélinée Peter-Derex, Laure Bastuji, Hélène Leslie, Wendy Schoendorff, Benjamin Heinzer, Raphael Siclari, Francesca Nicolas, Alain Lemoine, Patrick Higgins, Susan Bourgeois, Alexia Vallet, Guillaume T. Anders, Royce Ounnoughene, Marc Spencer, Jessica Meloni, Francesca Putois, Benjamin Int J Environ Res Public Health Review Benzodiazepines have proven to be highly effective for treating insomnia and anxiety. Although considered safe when taken for a short period of time, a major risk–benefit dilemma arises in the context of long-term use, relating to addiction, withdrawal symptoms, and potential side effects. For these reasons, benzodiazepines are not recommended for treating chronic sleep disorders, anxiety disorders, nor for people over the age of 65, and withdrawal among long-term users is a public health issue. Indeed, only 5% of patients manage to discontinue using these drugs on their own. Even with the help of a general practitioner, this rate does not exceed 25 to 30% of patients, of which approximately 7% manage to remain drug-free in the long term. Cognitive Behavioral Therapies (CBT) offer a crucial solution to this problem, having been shown to increase abstinence success to 70–80%. This article examines traditional and novel CBT techniques in this regard, such as Acceptance and Commitment Therapy, which address both the underlying condition (insomnia/anxiety) and the substance-related disorder. The theoretical framework and evidence supporting the use of these approaches are reviewed. Finally, current research gaps are discussed, and key research perspectives are proposed. MDPI 2021-09-28 /pmc/articles/PMC8508349/ /pubmed/34639523 http://dx.doi.org/10.3390/ijerph181910222 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Chapoutot, Mélinée Peter-Derex, Laure Bastuji, Hélène Leslie, Wendy Schoendorff, Benjamin Heinzer, Raphael Siclari, Francesca Nicolas, Alain Lemoine, Patrick Higgins, Susan Bourgeois, Alexia Vallet, Guillaume T. Anders, Royce Ounnoughene, Marc Spencer, Jessica Meloni, Francesca Putois, Benjamin Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders |
title | Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders |
title_full | Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders |
title_fullStr | Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders |
title_full_unstemmed | Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders |
title_short | Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders |
title_sort | cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508349/ https://www.ncbi.nlm.nih.gov/pubmed/34639523 http://dx.doi.org/10.3390/ijerph181910222 |
work_keys_str_mv | AT chapoutotmelinee cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT peterderexlaure cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT bastujihelene cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT lesliewendy cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT schoendorffbenjamin cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT heinzerraphael cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT siclarifrancesca cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT nicolasalain cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT lemoinepatrick cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT higginssusan cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT bourgeoisalexia cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT valletguillaumet cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT andersroyce cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT ounnoughenemarc cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT spencerjessica cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT melonifrancesca cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders AT putoisbenjamin cognitivebehavioraltherapyandacceptanceandcommitmenttherapyforthediscontinuationoflongtermbenzodiazepineuseininsomniaandanxietydisorders |